Sangui Biotech International
(OTC) SGBI
Sangui Biotech International Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$294.60K
Net Income (TTM)
$102.66K
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SGBI News
SGBI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sangui Biotech International
Industry
Biotechnology
Sector
Health CareCEO
Thomas Striepe, MBA
Website
www.sanguibiotech.comHeadquarters
Hamburg, 20354, DE
SGBI Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
55%
Net Income Margin
40%
Return on Equity
-35%
Return on Capital
-15%
Return on Assets
65%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$133.34K
Operating Income
$1.79K
EBITDA
$1.44K
Operating Cash Flow
$11.64K
Capital Expenditure
$0.00
Free Cash Flow
$11.64K
Cash & ST Invst.
$2.96K
Total Debt
$830.94K
Sangui Biotech International Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$64.68K
+62.2%
Gross Profit
$64.68K
+62.2%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$18.58K
-198.8%
EBITDA
$0.00
-100.0%
Quarterly Fundamentals
Net Cash
$631.33K
+23.8%
Accounts Receivable
$80.09K
+192.0%
Inventory
$0.00
-100.0%
Long Term Debt
$17.61K
-72.9%
Short Term Debt
$670.47K
-12.5%
Return on Assets
65.19%
N/A
Return on Invested Capital
-15.42%
N/A
Free Cash Flow
$107.18K
+1104.4%
Operating Cash Flow
$107.18K
+1104.4%